PatientsVille.com Logo

PULMONARY EMBOLISM and Medication

PatientsVille

PULMONARY EMBOLISM Symptoms and Causes

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung. Pulmonary embolism is a serious condition that can cause

  • Permanent damage to the affected lung
  • Low oxygen levels in your blood
  • Damage to other organs in your body from not getting enough oxygen

If a clot is large, or if there are many clots, pulmonary embolism can cause death.

Half the people who have pulmonary embolism have no symptoms. If you do have symptoms, they can include shortness of breath, chest pain or coughing up blood. Symptoms of a blood clot include warmth, swelling, pain, tenderness and redness of the leg. The goal of treatment is to break up clots and help keep other clots from forming.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for PULMONARY EMBOLISM

PULMONARY EMBOLISM treatment research studies

Medication clinical trials, surveys and public health registries


Find Drug Side Effect reports



Medication Side Effects


➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I was having frequent leg cramps. They worked their way from my foot up to my thigh. I just thought it was from stopping the use of muscle relaxers ( for a serious back and neck problem). I had forgotten about them and never mentioned it to either

I been on effexxor medication almost 2 weeks and i been having a nausea since i start i m desperate don t know what to do

I cannot swallow my pain medication and fluids seem to back up causing a cough, food is difficult to swallow and seems to lodge in my throat

I have very major problems . since taking medication been in the hospital twiced wih different complications ater taking augmentin

In Oct. 2009 I went to the Emergency Room of my local hospital for a shortness of breath as I was struggling to catch my breath. I was asked if I had chest pain and responded no, just difficulty breathing. I was given morphine, pr

My father died suddenly of a pulmonary Embolism with no signs or symtoms. We are devasted.....but the one thing that keeps pulling on my heart strings is he was already on blood thinners for years after his quadrapal by pass 13 years ago. He has been

On the 12th dec2011 i nearly died from a p. e. that had been going on for some time.I had a saddle on my lungs.I was 10 days in hospital & was treated with continued oxygen,clexane injections,warfaring pills,paracetamol pills,antibiotics in

What's on your mind...I am two months post PE after a total knee revision. Then three bleeds into the knee (big hematoma). Week later bleed and fluid into an already bad right shoulder requiring hospitalization. I am improving, however sleep an ext

My father is suffrering from idiotypic Pulmonary Fibrosis. In medication he is taking Prednisone,Perfenodone and azathropine. he is now geeting bleeding from his nose.Can anybody inform me that this is just a side effect of any d

After a pulmunary embolism diagnosis in April 2010, I was put on Warfarin for 11 months ... I was taken off it 1 week ago... While on it I experienced extreme lethargy , difficulty concentrating, memory loss, dizziness, ongoing ch

After being discharged from eER I saw in my file that the doppler impression shows mild tricuspid regurgitation and mild pulmonary hypertension =-O scared should I be worried

Completed course of interferon and ribavirn for Hepititis C. Fell pregnant 5 months after completion of treatment and gave birth to a baby boy weighing 7.6 lbs. He has Trisomy 21. He was born with Persisitant Pulmonary hypertension and a VSD. I do no

Female 39 years old from Denmark. Was treated with Octostim as a test. After drug was administred i experience this: <span style='font-weight: bold;'><a href='http://sideeffects101.com/drug-side-effects/o/octostim-pulmonary-oedema.htm' rel='

Has any one found legal representation willing to pursue pulmonary embolis caused by avandia

Having suffered 3 dvt's, 1 pulmonary embolism, 1 stroke and 2 tis's, I was given Fragmin. I previously had been taking warfarin for about 20 yrs, this ceased to work. I am now told that I have Osteoporosis... I seem to remember along the way that

Hello, im using trabectedin in a few weeks, after using ifoosfamide+doxorrubicin to treat pulmonary methastasis or a synovial sarcoma i am concened about loosin my hair again because it means too much for a woman and is not easy to use a wig in summ

How long can one live with the diagnosis of pulmonary hypertension? I have seen 3 to 5 years but I have had it for well over 10.

Husband has been taking avodart for 3 years. Developed a tightness in lungs, dry, non-productive cough, lungs feel a burning sensation. Thorough heart echo tests done, stress test. chest x-ray, mri, blood work, pulmonary function tests all passed.

PULMONARY EMBOLISM Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge
Conditions: Medication Reconciliation;   Adverse Drug Events
Intervention: Other: Electronic Medication Reconciliation
Outcome Measures: Adverse Drug Event;   Emergency Room Visit/Hospital Readmission;   Failure to re-start community Medications used for chronic conditions after discharge from hospital.;   Readiness for hospital discharge;   Time to complete medication history and discharge medication reconciliation with prescription.;   Therapy Duplication
2 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: Current ARV Medications;   Drug: Current TB Medications;   Drug: Current hormonal contraceptive Medications
Outcome Measures: Drug parameter: Area under the curve from 0 to 12 hours (AUC 0-12);   Drug parameter: Area under the curve from 0 to 24 hours (AUC 0-24);   Drug parameter: Maximum concentration (Cmax);   Drug parameter: Pre-dose concentration (Cdose);   Drug parameter: Minimum concentration (Cmin);   Drug parameter: Time after administration of drug when maximum plasma concentration is reached (Tmax);   Drug parameter: Clearance over systemic availability (Cl/F);   Drug parameter: Volume of distribution over systemic availability (V/F);   Drug parameter: Half-life (t1/2);   ARV concentrations in vaginal secretions;   ARV concentrations in plasma;   For contraceptives: plasma concentration;   Ratio of cord blood concentration to maternal blood concentration;   Ratio of unbound/total drug concentrations;   Rate of detection of study drugs in vaginal secretions;   Ratio of vaginal drug concentrations to simultaneous blood concentrations;   Rate of detection of HIV RNA/DNA in vaginal secretions and comparison to level in blood;   ARV exposure (as measured by area under the curve or other PK parameters) during pregnancy and postpartum according to genotype;   Adverse events of grade 3 or higher;   Infant neurological events of grade 1 or higher;   Adverse pregnancy outcome: preterm birth;   Adverse pregnancy outcome: low birth weight;   Adverse pregnancy outcome: fetal demise;   Adverse pregnancy outcome: congenital anomalies;   Infant HIV infection status
3 Unknown  Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
Conditions: Coronary Heart Disease;   Myocardial Infarction
Interventions: Other: Titration of Medications;   Behavioral: Lifestyle Counseling;   Behavioral: Medication Counseling;   Other: Usual Care with Medication Reconciliation
Outcome Measures: Percentage of patients at guideline goal for both blood pressure and lipids;   Composite cardiovascular morbidity and all-cause mortality;   Patient Satisfaction with Clinical Pharmacist Services;   Change in Adherence with 8-item Morisky Adherence Tool
4 Not yet recruiting Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions
Condition: Hyperkalemia
Intervention: Behavioral: decision support in potassium-inc. drug-drug-interactions
Outcome Measures: Impact on serum potassium monitoring during potassium-increasing drug-drug-interactions;   Frequency of hyperkalemia during potassium-increasing drug-drug-interactions;   Frequency of potassium-increasing drug-drug-interactions ordered in the presence of hyperkalemia;   Frequency of transfers to the ICU during potassium-increasing drug-drug-interactions in function of the serum potassium level;   Frequency of death during potassium-increasing drug-drug-interactions in the presence or absence of hyperkalemia;   Change in frequency distribution of serum potassium monitoring intervals;   Response of physicians to the computer-based alerts and reminders
5 Recruiting The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes
Conditions: Medication Adherence;   Blood Pressure
Intervention: Device: Medication reminder
Outcome Measures: self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool;   systolic blood pressure in mmHg using a valid automated device
6 Recruiting Multidisciplinary Program "Optimization of Drug Prescription" : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients
Condition: Potentially Inappropriate Medications
Intervention: Other: " Optimisation de la Prescription MEDicamenteuse " ("Optimization of drug prescribing")
Outcome Measures: Proportion of potentially inappropriate Medications (PIM) prescribed in discharge of hospitalized patients from 75 years old.;   Total number of drugs prescribed per discharge prescription sheet;   Number of rehospitalization within 12 months following discharge;   Number of emergency admission within 12 months following hospitalization;   Mortality within 12 months after hospitalization
7 Recruiting Multi-Center Medication Reconciliation Quality Improvement Study
Conditions: Adverse Drug Events;   Medication Administered in Error
Intervention: Other: Mentored medication reconciliation quality improvement
Outcome Measures: The primary outcome will be unintentional medication discrepancies in admission orders and discharge orders with potential for patient harm;   Patient satisfaction;   Administrative outcomes
8 Not yet recruiting A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Salbutamol (Ventolin®);   Drug: Formoterol (Oxis Turbuhaler®);   Drug: Salmeterol / fluticasone (Seretide®);   Drug: Bufei granule;   Drug: Bufeijianpi granule;   Drug: Bufeiyishen granule;   Drug: Yiqizishen granule;   Drug: conventional medicine + TCM
Outcome Measures: the frequency of exacerbation;   Forced expiratory volume in one second;   Dyspnea;   6 Minutes Walking Distance Test(6MWD);   Quality of life;   Economic Evaluation
9 Recruiting Improving Communication of Medication Instructions to Parents
Conditions: Medication Errors;   Medication Adherence
Intervention: Other: HELPix
Outcome Measure: Medication dosing error (observed)
10 Recruiting The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.
Conditions: Adverse Drug Event;   Patient Readmission;   Patient Compliance
Intervention: Behavioral: HomeCoMe-program
Outcome Measures: Identifying and solving adverse drug events (ADEs) and other drug-related problems (DRPs) post-discharge;   Improvement of adherence to medication at hospital discharge;   Patient assessment of medication knowledge at time of home visit;   Types of interventions made at the pharmacist home visit;   Patient satisfaction with the pharmacist home visit;   Assessment of patient reported health rating;   General practitioners satisfaction with the pharmacist home visit
11 Not yet recruiting Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Condition: Adverse Drug Events
Interventions: Other: Pharmacist obtains admission medication history;   Other: Pharmacy technician obtains admission medication history
Outcome Measure: Medication History Errors, or Medication Order Errors
12 Recruiting the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
Conditions: Adverse Drug Reaction;   Medication Administered in Error
Intervention: Other: integrated medicines management
Outcome Measures: number of rehospitalizations;   numbers of ADEs;   numbers of DRPs;   cost per prevented re-hospitalization;   general health care use
13 Recruiting Regional Data Exchange to Improve Medication Safety
Condition: Drug Toxicity
Intervention: Other: Medication reconciliation enhanced by regional health information exchange
Outcome Measures: Transition drug risk;   Adverse drug events;   Care duplication;   Transitional care satisfaction "Care Transitions Measure"
14 Recruiting Comparison of Drug Eluting Balloon and Drug Eluting Stent
Conditions: Coronary Artery Disease;   Stable Angina;   Unstable Angina;   NSTEMI
Interventions: Device: Drug eluting balloon + Bare metal stent;   Device: drug eluting stent (Zotarolimus-eluting stent)
Outcome Measures: in-segment late loss;   stent thrombosis;   angiographic and procedure success;   MACE
15 Not yet recruiting Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Condition: 1. Major Depressive Disorder.
Interventions: Device: Supplemental TMS;   Drug: Standard Medication Monotherapy
Outcome Measures: Montgomery-Åsberg Depression Rating Scale (MADRS);   Hamilton Rating Scale for Depression (HRSD)
16 Recruiting Pharmacist-led Medicines Management Outpatient Service
Condition: High Risk of Medication-related Problems
Intervention: Other: Medicines Management Outpatient service
Outcome Measures: Time to readmission to hospital;   Number of Readmission;   Number of GP consultations and GP home visits;   Number of Accident and Emergency (A&E) visits;   Medication Appropriateness Index (MAI) score;   Health-related quality of life (HRQOL);   Medication Adherence Assessments;;   Cost Utility Analysis
17 Unknown  Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
Condition: Adverse Drug Event
Intervention: Behavioral: Active medication monitoring
Outcome Measures: Adverse drug event detection;   Adverse drug event response time
18 Not yet recruiting ADHD Medication and Predictors of Treatment Outcome
Condition: Attention Deficit Disorder With Hyperactivity (ADHD)
Interventions: Drug: methylphenidate medication;   Drug: atomoxetine medication;   Drug: lisdexamphetamine medication
Outcome Measures: change in SNAP-IV Teacher and Parent rating scale (Swanson, Nolan and Pelham ADHD Rating Scale);   change in P-SEC (Pediatric Side Effects Checklist);   change in CGI-S (Clinical Global Impression- of Severity);   change in C-GAS (Children´s global assessment scale);   change in SNAP-IV Teacher and Parent rating scale;   change in Spence Children's Anxiety Scale (SCAS);   change in heart rate;   change in systolic blood pressure;   change in diastolic blood pressure;   change in weight z-score;   change in height z-score
19 Recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
Outcome Measures: Microfilaria prevalence based on results of microscopic examination of blood smears and skin snips.;   Prevalence of filarial antigenemia in blood and intensity of filarial and intestinal worm infections based on results of microscopy.
20 Not yet recruiting Observational Study to Reduce Medication Errors
Condition: Medication Errors
Intervention:
Outcome Measures: Number of participants with adverse drug reactions due to medication errors occurring during hospitalization;   Number of participants with preventable ADRs due to medication errors